A previous study (47) demonstrated that EMT is involved in the process of metastatic dissemination to the brain, and the EMT driver genes that were upregulated in our study (SOX10, TWIST1, CDH2) may have potential as biomarkers in risk stratification for BM in suspected early-stage lung cancer. The gene discussed is CDH2; the disease is lung cancer.